Breaking News, Collaborations & Alliances

Financial Report: Patheon

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 3Q Revenues: $175.5 million (-2%) 3Q Loss: $63.1 million (loss of $257.2 million in 3Q2006) YTD Revenues: $510.3 million (flat) YTD Loss: $87.1 million (loss of $265.7 million YTD2006) Comments: Rx manufacturing revenues increased by $5.6 million or 4% in the quarter, driven by growth in Europe, partially offset by declines in Canada and PR. PDS revenues increased by $3.2 million, or 12%, due to growth at the Swindon and Cincinnati operations. OTC revenues declined $1...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters